We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure. For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived. We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news

Increasing HPV vaccine uptake in adolescents
(University of Pennsylvania School of Nursing) More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 1, 2020 Category: Cancer & Oncology Source Type: news

Uganda: Uganda Yet to Embrace Hpv Vaccination
[Monitor] he magic bullet to stop the infamous cervical cancer rise, according to experts lies in Human papillomavirus (HPV) vaccination. Countries have since launched several vaccination campaigns as recommended by different world health bodies and specific organisations in the cancer battle. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 23, 2020 Category: African Health Source Type: news

Interventions to Increase HPV Vaccine Coverage Cost-Effective
MONDAY, Nov. 16, 2020 -- Three interventions for increased human papillomavirus (HPV) vaccine coverage are cost-effective, according to a study published online Nov. 16 in Pediatrics. Jennifer C. Spencer, Ph.D., from the Harvard T.H. Chan School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2020 Category: Pharmaceuticals Source Type: news

Black College Students, Especially Women, Delay HPV Vaccination Black College Students, Especially Women, Delay HPV Vaccination
The human papillomavirus (HPV) disproportionately affects people of color and Black gay men, yet many within these communities do not receive the HPV vaccine, most notably college-aged women of color.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 15, 2020 Category: Infectious Diseases Tags: Nursing News Source Type: news

HPV Vaccine Generally Well Tolerated in Males
WEDNESDAY, Nov. 4, 2020 -- Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology. Giulia Bonaldo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Remains Below Healthy People Goals HPV Vaccination Remains Below Healthy People Goals
Rates of human papillomavirus vaccination increased for both boys and girls in the United States over the past decade but remain below target levels and vary widely among states.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 14, 2020 Category: Infectious Diseases Tags: Pediatrics News Source Type: news

Quality Improvement Coaching for Human Papillomavirus Vaccination Coverage: A Process Evaluation in 3 States, 2018-2019
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 8, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Impact of HPV vaccination mandates on social inequalities
(University of California - Riverside) A postdoctoral researcher at the University of California, Riverside, has discovered Human papillomavirus, or HPV, vaccination mandates fall short of ensuring both higher levels of uptake and equal uptake of the vaccine across socioeconomic and racial-ethnic groups. The findings could help facilitate equal access to and compliance with uptake of COVID-19 vaccines, once they are available. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 5, 2020 Category: Infectious Diseases Source Type: news

HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
THURSDAY, Oct. 1, 2020 -- Quadrivalent human papillomavirus (HPV) vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer, according to a study published in the Oct. 1 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccine Proves Its Mettle Against Cervical Cancer
WEDNESDAY, Sept. 30, 2020 -- Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds. Researchers found that of more than 1.6 million young... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2020 Category: General Medicine Source Type: news

A Cross-Sectional Survey to Evaluate Potential for Partnering With School Nurses to Promote Human Papillomavirus Vaccination
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - September 24, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rates Increasing Among 15-Year-Olds
MONDAY, Sept. 14, 2020 -- From 2011 to 2017, there was an increase in the proportion of U.S. 15-year-olds with at least one-dose or two-dose human papillomavirus (HPV) vaccination, according to a study published online Sept. 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rises Among U.S. Kids, But Many Still Unprotected
MONDAY, Sept. 14, 2020 -- More U.S. kids are getting a recommended vaccine that protects against several cancers -- but there is still much room for improvement, a new study finds. At issue is the vaccine against human papillomavirus (HPV). Certain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2020 Category: General Medicine Source Type: news

HPV vaccination linked to lower risk of precancerous condition
(Wiley) Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

ACS Disagrees With CDC on HPV Vaccination in Adults ACS Disagrees With CDC on HPV Vaccination in Adults
The American Cancer Society's new guidance on human papillomavirus vaccination diverges from the Centers for Disease Control and Prevention's recommendations.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 3, 2020 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Teen HPV Vaccination Rates Suboptimal
THURSDAY, July 30, 2020 -- Lack of parental intent to initiate and complete the human papillomavirus (HPV) vaccine series for adolescents is a major public health concern, according to a study published online July 21 in The Lancet Public... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 30, 2020 Category: Pharmaceuticals Source Type: news

HPV Shots: Safe and Effective, But Many Parents Still Hesitate
WEDNESDAY, July 29, 2020 -- More than a decade of research has shown that the human papillomavirus (HPV) vaccine protects against a host of cancers, yet a new study finds that only half of American teens complete the multiple-shot regimen. Why?... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2020 Category: General Medicine Source Type: news

American Cancer Society Updates HPV Vaccination Guidelines
WEDNESDAY, July 8, 2020 -- The American Cancer Society has updated guidelines on human papillomavirus (HPV) vaccination, emphasizing that vaccination should be routinely offered at age 9 to 12 years; the updated recommendations were published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2020 Category: Pharmaceuticals Source Type: news

Study: 'Anti-vaxxers' gain traction against HPV vaccine on Facebook
(University of Missouri-Columbia) One of the biggest social media sites -- Facebook -- has allowed " anti-vaxxers " to gain a stronger voice against the use of the human papillomavirus, or HPV, vaccine, according to a new study from a media expert at the University of Missouri. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2020 Category: Cancer & Oncology Source Type: news

School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news

Multilevel Interventions May Boost HPV Vaccination Rates
FRIDAY, June 19, 2020 -- Multilevel, provider-oriented interventions may improve human papillomavirus (HPV) vaccine series initiation and completion, according to a study published in the June 1 issue of Pediatrics. Rebecca B. Perkins, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves HPV Vaccine Gardasil As Throat Cancer Prevention
The HPV vaccine (Gardasil 9) has been approved by the Food and Drug Administration (FDA) for males and females ages 9 to 45 years to prevent HPV-related genital tract and anogenital infections and cancers for several years. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 17, 2020 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Gardasil-9 Approved for Prevention of Head and Neck Cancers Gardasil-9 Approved for Prevention of Head and Neck Cancers
The FDA has expanded the indication for the Gardasil-9 vaccine to include the prevention of head and neck cancersMedscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 15, 2020 Category: Primary Care Tags: Hematology-Oncology News Source Type: news

Multilevel interventions improve HPV vaccination rates of series initiation and completion
(Boston Medical Center) New research from Boston Medical Center shows that providing education and training to pediatric and family medicine providers about the importance of human papillomavirus (HPV) vaccines, in tandem with healthcare systems changes including starting an HPV vaccination series before the age of 11, improves the overall rate of HPV vaccinations among adolescent patients. HPV vaccinations can help reduce rates of HPV-related cancers, as well as play a role in reducing race- and income-related disparities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2020 Category: Cancer & Oncology Source Type: news

FDA Approves Merck ’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
KENILWORTH, N.J.--(BUSINESS WIRE) June 12, 2020 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Gardasil 9 for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 15, 2020 Category: Drugs & Pharmacology Source Type: news

HPV Vaccines That Work in U.S. Women May Miss the Target in Women From Other Countries
A research team at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective in protecting other populations of women from the disease. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - June 4, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release cancer Norris Cotton Cancer Center Source Type: news

Wording of vaccination messages influences behavior
(Washington State University) An experiment by Washington State University researchers revealed that relatively small differences in messages influenced people's attitudes about the human papillomavirus or HPV vaccine, which has been shown to help prevent cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

HPV vaccines that work in US women may miss the target in women from other countries
(Dartmouth-Hitchcock Medical Center) Most cervical cancers are caused by persistent infection with high-risk human papillomavirus (hrHPV). Different vaccines are available to protect against HPV. Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have shown a very different prevalence of hrHPV in Honduras compared to the United States, and concluded that the same vaccination programs that target hrHPV strains in the U.S. may not be as effective in protecting women in other countries from the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2020 Category: Cancer & Oncology Source Type: news

Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts
A young boy in Pakistan receives an oral polio vaccine (OPV). Credit: Ashfaq Yusufzai/IPSBy Laura MackenzieMay 6 2020 (IPS) Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn. A growing number of one-off immunisation campaigns and national routine vaccine introductions are being delayed amid social distancing and other measures to curb the spread of SARS-CoV-2, leaving millions unprotected. With both preventive campaigns and routine immunisations impacted, “we’ll have an increasing number of children who will becom...
Source: IPS Inter Press Service - Health - May 6, 2020 Category: International Medicine & Public Health Authors: Laura Mackenzie Tags: Global Headlines Health TerraViva United Nations Source Type: news

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
             Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval ...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Human Papillomavirus Vaccination Estimates Among Adolescents in the Mississippi Delta Region: National Immunization Survey ‑Teen, 2015-2017
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - April 16, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Therapeutic HPV vaccine may improve outcomes in advanced cervical cancer
(American Association for the Advancement of Science) Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may extend survival in patients with advanced, recurrent cervical cancer, according to a phase 1/2 trial involving 77 patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 18, 2020 Category: Cancer & Oncology Source Type: news

Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - March 12, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

HPV infections can be eliminated if both boys and girls are vaccinated
(Karolinska Institutet) The human papillomavirus (HPV) causes, amongst other diseases, cancer of the cervix and oropharynx. A Swedish-Finnish study published in The Journal of Infectious Diseases now shows that the most oncogenic HPV types can be eliminated, but only if both girls and boys are vaccinated. Both genders will be offered vaccination in Sweden as of 2020. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 12, 2020 Category: Cancer & Oncology Source Type: news

Young men unaware of risks of HPV infection and need for HPV vaccination
(Rutgers University) Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus (HPV) due to a lack of information from health care providers, according to Rutgers researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2020 Category: International Medicine & Public Health Source Type: news

One HPV Vaccine Dose May Be As Effective As Multiple, Study Finds
BOSTON (CBS) — It is currently recommended that boys and girls under age 15 get two doses of the human papillomavirus (HPV) vaccine but a new study published in the journal Cancer finds that just one dose may be as effective. HPV is the most common sexually transmitted infection and certain strains of the virus are associated with cervical cancer in women. Researchers at the University of Texas looked at more than 130,000 females and found that one dose of the HPV vaccine was as effective as multiple doses for preventing cervical changes that often lead to cervical cancer. The hope is that if only one dose is require...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 10, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HPV vaccine Source Type: news

Single Dose of HPV Vaccine May Cut Preinvasive Cervical Disease
MONDAY, Feb. 10, 2020 -- Receipt of one, two, or three doses of the human papillomavirus (HPV) vaccine among females aged 15 to 19 years is associated with reduced incidence of preinvasive cervical disease at five years compared to that seen in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 10, 2020 Category: Pharmaceuticals Source Type: news

One Dose of HPV Vaccine May Protect Against Cervical Cancer
MONDAY, Feb. 10, 2020 -- A single dose of the human papillomavirus (HPV) vaccine works as well as multiple doses to protect older teen girls against preinvasive cervical disease, which can develop into cervical cancer, researchers say. For the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 10, 2020 Category: General Medicine Source Type: news

Single HPV vaccine dose may be effective against cervical cancer
(Wiley) New research published in CANCER indicates that a single dose of the human papillomavirus (HPV) vaccine is as effective as multiple doses for preventing preinvasive cervical disease, which can later develop into cervical cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

Cancer-causing HPV can hit you even if you had the vaccination
Jessica Donald, from Birmingham, thought she'd get the all-clear after a cervical cancer screening test at her GP - only to be told she'd tested positive for human papillomavirus. (Pictured, stock image.) (Source: the Mail online | Health)
Source: the Mail online | Health - February 8, 2020 Category: Consumer Health News Source Type: news

Non-Vaccine Oncogenic HPV Genotypes Persist in HPV-Vaccinated Women With HIV Non-Vaccine Oncogenic HPV Genotypes Persist in HPV-Vaccinated Women With HIV
Women living with HIV who received quadrivalent human papillomavirus (HPV) vaccination still face the risk of infection with non-vaccine oncogenic HPV genotypes, researchers from Canada report.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 8, 2020 Category: Pathology Tags: HIV/AIDS News Source Type: news

UN Health Agency Predicts 80 Percent Rise in Cancer Burden Among Poorest Countries
Many specialist doctors and nurses in Africa are migrating to greener pastures, leaving cancer patients with few options. Credit: Jeffrey Moyo/IPSBy External SourceLONDON, Feb 7 2020 (IPS) Low- and middle-income countries could see an 80 per cent rise in cancer over the next 20 years if treatment and prevention services are not stepped up, according to the latest World Cancer Report. The report, compiled by the World Health Organization (WHO), warns that cancer prevention is taking a back seat in poor countries, as their health systems tackle such immediate problems as infectious diseases, child health and nutrition. The r...
Source: IPS Inter Press Service - Health - February 7, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs Source Type: news

Whether HPV Vaccination Will Prevent Cervical Cancer Unclear
MONDAY, Feb. 3, 2020 -- Methodological problems and study limitations for trials of the human papillomavirus (HPV) vaccine create uncertainty about its ability to prevent cervical cancer in the long term, according to a review published online Jan.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2020 Category: Pharmaceuticals Source Type: news

The Damage of Vaccine Misinformation
From 2013 to 2016, negative information about the HPV (human papillomavirus) vaccine spread widely through Danish media outlets. As a result, thousands of girls did not receive the vaccine. (Source: WebMD Health)
Source: WebMD Health - January 23, 2020 Category: Consumer Health News Source Type: news

The Damage of Vaccine Misinformation
THURSDAY, Jan. 23, 2020 -- An examination of vaccination trends in Denmark shows just how damaging vaccine misinformation can be. From 2013 to 2016, negative information about the HPV (human papillomavirus) vaccine spread widely through Danish... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 23, 2020 Category: General Medicine Source Type: news

The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015.
CONCLUSIONS:The authors found relatively higher and increasing incidence rate of OPC in Florida and lower rate of HPV vaccination among adolescents in Florida than in the nation overall.PRACTICAL IMPLICATIONS:The trends illustrated may stimulate policy changes to increase HPV vaccination for children and enhance the understanding of its benefits. (Source: Dental Technology Blog)
Source: Dental Technology Blog - January 22, 2020 Category: Dentistry Source Type: news

HPV vaccine minimises impact of cancer-causing infections
Cancer-causing HPV16 and 18 infections are now extremely uncommon in young sexually active women in England, following the introduction of HPV (human papillomavirus) vaccination in 2008. (Source: NHS Networks)
Source: NHS Networks - January 21, 2020 Category: UK Health Source Type: news